PMGC Holdings (ELAB) Intangibles (2024 - 2026)
PMGC Holdings (ELAB) posted Intangibles of $3.8 million for Q1 2026, up 31.4% sequentially from $2.9 million in Q4 2025, and up 83.37% YoY from $2.1 million in Q1 2025.
PMGC Holdings (ELAB) Intangibles (2024 - 2026) Analysis & Trends
PMGC Holdings has reported Intangibles for 3 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Intangibles rose 83.37% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 83.37% YoY) and the FY2025 annual result came in at $2.9 million, changed 0.27% from the prior year.
- Intangibles climbed to $3.8 million in Q1 2026 per ELAB's latest filing, from $2.9 million in the prior quarter.
- Over five years, Intangibles peaked at $3.8 million in Q1 2026 and troughed at $843505.0 in Q1 2024.
- A 3-year average of $2.5 million and a median of $2.8 million in 2024 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 145.72% in 2025, down 27.15% in 2025.
- Over 3 years, Intangibles stood at $2.9 million in 2024, then climbed by 0.27% to $2.9 million in 2025, then soared by 31.4% to $3.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $3.8 million, $2.9 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Mar 31, 2024 | 843,505.00 |